@article{b028aa2ee1954add9640e01c74aac3a0,
title = "Marking the 50th anniversary of a seminal paper in rheumatology: Did Baruj Benacerraf and Hugh McDevitt get it right?",
keywords = "arthritis, rheumatoid, autoimmunity, lupus erythematosus, systemic",
author = "Rosenbaum, {James Todd} and Tejpal Gill and Martin, {Tammy M.} and Marcia Friedman and Reid Thompson",
note = "Funding Information: Funding This work was supported by NIH Grant NEI RO1 EY029266, NCATS KL2R002370 and P30 EY010572; the Oregon Health & Science University Department of Medicine Wheels Up Award; the Medical Research Foundation of Oregon; and donations from the Stan and Madelle Rosenfeld Family Trust, the Grandmaison Fund for Autoimmunity Research, the William and Mary Bauman Foundation, and Research to Prevent Blindness. TG is the recipient of the Jane Bruckel Early Career Investigator Award from the Spondylitis Association of America. Funding Information: Competing interests JTR consults for Abbvie, Novartis, Gilead, UCB, Corvus, Revolo, Neoleukin, Santen, Affibody and Horizon. He receives grant support from Horizon, the Malassezia Foundation and Pfizer. He receives royalties from UpToDate. He serves on a data monitoring board for Celgene-BMS. MF consults for Revolo.",
year = "2022",
month = may,
day = "1",
doi = "10.1136/annrheumdis-2022-222131",
language = "English (US)",
volume = "81",
pages = "618--621",
journal = "Annals of the rheumatic diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "5",
}